February 17-19, 2026 | Washington, D.C.

Hosted by the Administration for Strategic Preparedness and Response’s Biomedical Advanced Research and Development Authority (BARDA), Radiological and Nuclear Medical Countermeasures Program, in collaboration with the Defense Health Agency, Research and Engineering, Combat Casualty Care Portfolio and the Medical Technology Enterprise Consortium (MTEC).

The meeting will focus on advancing platelet and platelet-like products to meet critical military and civilian needs in combat and disaster scenarios, while providing insights into government funding opportunities and fostering discussions on emerging technologies such as extracellular vesicles, synthetic nanoparticles, and clinical trial updates.

The event will feature:

• focused networking with fellow platelet developers,
• topical discussions spanning evolutionary biology to translational challenges,
• company lightning pitches from innovators across the field,
• an interactive poster session,
• and a networking reception.